FindMyKOL
Clinical trialNCT03562364CompletedInterventional

Early Advanced Weight Bearing for Peri-articular Knee and Pilon Injuries

NCT03562364 is an interventional trial sponsored by Major Extremity Trauma Research Consortium. As of 21 Nov 2026, it is completed. It studies Distal Femur Fracture, Distal Tibia Fracture and 2 more conditions. The registry lists an enrollment of 81 participants at 10 sites in 1 country. The registry lists a start date of 25 Feb 2019 and a primary completion date of 30 Oct 2022.

SponsorMajor Extremity Trauma Research ConsortiumEnrollment81Distal Femur FractureDistal Tibia FracturePilon FractureTibial Plateau Fracture
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03562364
FieldValue
Registry IDNCT03562364
StatusCompleted
Study typeInterventional trial
Lead sponsorMajor Extremity Trauma Research Consortium
Enrollment81
Registered sites10
Countries1
ConditionsDistal Femur Fracture, Distal Tibia Fracture, Pilon Fracture and Tibial Plateau Fracture
Start25 Feb 2019
Primary completion30 Oct 2022
Study completion30 Oct 2022
Last update posted22 Dec 2023

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The overall objective of this study is to compare outcomes following early advanced weight bearing (EAWB) using the AlterG antigravity treadmill versus standard of care physical therapy for adult patients with lower extremity periarticular injuries.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States2 sites
  • Naval Medical Center San Diego

    San Diego

  • University of California at San Francisco

    San Francisco

Kentucky, United States1 site
  • University of Kentucky

    Lexington

Maryland, United States1 site
  • Walter Reed National Military Medical Center

    Bethesda

Minnesota, United States1 site
  • Hennepin County Medical Center

    Minneapolis

Texas, United States2 sites
  • University of Texas Health Science Center - Houston

    Houston

  • San Antonio Military Medical Center (sammc)

    San Antonio

Virginia, United States3 sites
  • University of Virginia

    Charlottesville

  • Inova Fairfax Hospital

    Falls Church

  • Naval Medical Center Portsmouth

    Portsmouth

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 2 sitesCA2NevadaNVWyomingWYNebraskaNEMissouriMOKentucky: 1 siteKY1West VirginiaWVVirginia: 3 sitesVA3Maryland: 1 siteMD1DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 2 sitesTX2FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03562364

Each answer restates registry values shown on this page.

What is NCT03562364?

NCT03562364 is an interventional trial sponsored by Major Extremity Trauma Research Consortium. It studies Distal Femur Fracture, Distal Tibia Fracture and 2 more conditions.

Who leads NCT03562364?

The registry names Daniel Stinner, MD (principal investigator, Vanderbilt University Medical Center) as the overall official.

Where does NCT03562364 run?

The registry lists 10 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT03562364 end?

The registry lists a primary completion date of 30 Oct 2022 and a study completion date of 30 Oct 2022. The sponsor last updated the record on 22 Dec 2023.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.